Sat 19 June 2021
Warszawa (PL)
28/17°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 27 | 30 | 31 | 30 | 29 |
Sat 19 June 2021
Praha (CZ)
Sat 19 June 2021
Bratislava (SK)
19/16°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 30 | 31 | 32 | 32 | 33 |
Sat 19 June 2021
Budapest (HU)
26/19°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 29 | 30 | 32 | 31 | 30 |
US pharma Acadia buys Polish drug rights
March 17th, 2021
US pharmaceutical company Acadia has purchased the exclusive rights to the development of a new neuropsychiatric drug from the Polish company Adamed in a deal worth above PLN 470 million (EUR 102m). Adamed has carried out the transaction at an early stage of research, the Puls Biznesu economic newspaper reported. "We are granting an exclusive licence for the further development of the drug," the newspaper was told by Bartlomiej Zerek, Innovation Department director at Adamed.
PAP